[Federal Register: September 29, 2006 (Volume 71, Number 189)]
[Notices]
[Page 57571]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29se06-129]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated May 17, 2006, and published in the Federal Register
on May 25, 2006, (71 FR 30167), Stepan Company, Natural Products Dept.,
100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the basic classes of controlled substances
listed in Schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cocaine (9041)............................. II
Benzoylecgonine (9180)..................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Stepan Company to manufacture the listed basic classes of controlled
substances is consistent with the public interest at this time. DEA has
investigated Stepan Company to ensure that the company's registration
is consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above
named company is granted registration as a bulk manufacturer of the
basic classes of controlled substances listed.
Dated: September 20, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator,Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-16054 Filed 9-28-06; 8:45 am]
BILLING CODE 4410-09-P